Table 1 The baseline characteristics of participants
BRI | Q1 (< 2.09) | Q2 (2.09–< 2.63) | Q3 (2.63–< 3.23) | Q4 (≥ 3.23) | P value |
|---|---|---|---|---|---|
Participants | 3828 | 3827 | 3827 | 3828 | |
Age, years | 40.80 ± 8.39 | 42.67 ± 8.47 | 44.56 ± 8.54 | 46.75 ± 9.04 | < 0.001 |
Gender—n (%) | < 0.001 | ||||
Female | 2414 (63.062%) | 1790 (46.773%) | 1406 (36.739%) | 1336 (34.901%) | |
Male | 1414 (36.938%) | 2037 (53.227%) | 2421 (63.261%) | 2492 (65.099%) | |
Smoking status | < 0.001 | ||||
Never-smoker | 2675 (69.88%) | 2284 (59.68%) | 2007 (52.44%) | 1962 (51.25%) | |
Past-smoker | 451 (11.78%) | 697 (18.21%) | 878 (22.94%) | 912 (23.82%) | |
Current-smoker | 702 (18.34%) | 846 (22.11%) | 942 (24.61%) | 954 (24.92%) | |
Ethanol consumption g/wk | 31.38 ± 63.84 | 48.00 ± 80.30 | 55.92 ± 89.75 | 56.57 ± 90.76 | < 0.001 |
Habit of exercise | 689 (18.00%) | 758 (19.81%) | 676 (17.66%) | 573 (14.97%) | < 0.001 |
WC (m) | 0.66 ± 0.05 | 0.73 ± 0.04 | 0.79 ± 0.04 | 0.86 ± 0.06 | < 0.001 |
BMI (kg/m2) | 19.02 ± 1.53 | 21.02 ± 1.52 | 22.69 ± 1.70 | 25.35 ± 2.45 | < 0.001 |
FBG (mmol/L) | 4.99 ± 0.39 | 5.11 ± 0.39 | 5.22 ± 0.40 | 5.32 ± 0.39 | < 0.001 |
HbA1c(%) | 5.104 ± 0.303 | 5.138 ± 0.308 | 5.177 ± 0.318 | 5.257 ± 0.334 | < 0.001 |
TC (mmol/L) | 4.87 ± 0.81 | 5.02 ± 0.83 | 5.20 ± 0.85 | 5.40 ± 0.85 | < 0.001 |
TG (mmol/L) | 0.53 (0.38–0.73) | 0.65 (0.46–0.96) | 0.84 (0.58–1.24) | 1.05 (0.70–1.55) | < 0.001 |
HDL-C (mmol/L) | 1.66 ± 0.40 | 1.527 ± 0.392 | 1.386 ± 0.381 | 1.281 ± 0.346 | < 0.001 |
GGT (U/L) | 14.41 ± 11.20 | 18.11 ± 15.27 | 21.98 ± 20.19 | 26.34 ± 21.24 | < 0.001 |
ALT (U/L) | 14.00 (11.00–18.00) | 15.00 (12.00–20.00) | 18.00 (13.00–24.00) | 21.00 (16.00–31.00) | < 0.001 |
AST (U/L) | 16.00 (13.00–19.00) | 17.00 (14.00–20.00) | 18.00 (14.00–21.00) | 19.00 (15.00–24.00) | < 0.001 |
SBP (mmHg) | 106.89 ± 12.80 | 111.91 ± 13.06 | 116.32 ± 13.91 | 122.08 ± 15.14 | < 0.001 |
DBP (mmHg) | 66.40 ± 8.82 | 69.62 ± 9.36 | 72.95 ± 10.05 | 76.88 ± 10.47 | < 0.001 |